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Background: About one third of hospital mortality in critically ill patients occurs after Intensive Care Unit (ICU)
discharge. Some authors have recently hypothesized that unresolved or latent inflammation and sepsis may be an
important factor that contributes to death following successful discharge from the ICU.
Aim: The aim of our study was to determine the ability of the clinical and inflammatory markers at ICU discharge
to predict post-ICU mortality.
Methods: A prospective observational cohort study was conducted during a 14-month period in an 8 bed
polyvalent ICU. Acute Physiology and Chronic Health Evaluation (APACHE) II score, Simplified Acute Physiology
Score (SAPS) II, Sequential Organ Failure Assessment (SOFA) score, Therapeutic Intervention Scoring System-28
(TISS-28), C-reactive protein (CRP), white cell count (WCC) and body temperature of the day of ICU discharge were
collected from patients who survived their first ICU admission.
Results: During this period 156 patients were discharged alive from the ICU. A total of 29 patients (18.6%) died
after ICU discharge. There were no differences in clinical and demographic characteristics between survivors and
nonsurvivors. C-reactive protein levels at ICU discharge were not significantly different between survivors and
nonsurvivors. The area under receiver operating characteristics curves of APACHE II, SAPS II, SOFA, TISS-28, CRP,
WCC and body temperature at ICU discharge as prognostic markers of hospital death were 0.76 (95% confidence
interval (CI) 0.67-0.86); 0.75 (95% CI 0.66-0.85); 0.72 (95% CI 0.62-0.83); 0.64 (95% CI 0.52-0.77); 0.55 (95% CI 0.43-0.67);
0.55 (95% CI 0.42-0.66) and 0.54 (95% CI 0.44-0.67) respectively. The hospital mortality rate of the patients with CRP
<5, 5-10, >10 mg/dL was 15.1%, 16.1% and 33.3% respectively (p = NS).
Conclusions: At ICU discharge serum CRP concentration was a poor marker of post-ICU prognosis. Post-ICU death
appears to be unrelated to the persistent inflammatory response.
Background
Critically ill patients are responsible for 10-25% global
hospital costs [1]. The ability to identify critically ill
patients who will not survive until hospital discharge
may allow identification of high risk patients leading to
more conservative strategies of ICU discharge.
About one third of hospital mortality of critically
ill patients occurs after Intensive Care Unit (ICU)
discharge [2].
Smith et al. observed in 283 patients discharged from
the ICU to hospital wards that patients with higher
Therapeutic Intervention Scoring System (TISS)-28 had
higher post-ICU mortality (TISS-28 >20 = 21.4% vs.
TISS-28 <10 = 3.7%, p < 0,0001) [3]. Several other risk-
prediction models have been used to predict in-hospital
mortality after patient discharge from the ICU [4,5].
However risk estimated by these models showed consid-
erable variation across the disease spectrum of ICU
patients.
Post ICU deaths arise mainly as a result of incomplete
resolution of the primary condition or from the develop-
ment of new complications [6-8]. Some authors have
recently hypothesized that unresolved or latent inflam-
mation and sepsis may be an important factor that
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any medium, provided the original work is properly cited.contributes to death following successful discharge from
the ICU [6].
In two recent studies with critically ill patients, a high
CRP concentration at ICU discharge was associated with
a subsequent increase in in-hospital mortality [6,9].
The aim of our study was to determine the ability of
the clinical and inflammatory markers at ICU discharge
to predict post ICU mortality.
Methods
This study was a prospective, single center, observa-
tional study conducted during a 14-month period in the
ICU of Garcia de Orta Hospital, an 8-bed multidisciplin-
ary ICU.
The Hospital Ethics Committee approved the study
design, and informed consent was waived because this
was an observational study without any deviation from
the current medical practice.
Patients were included in the study if they were dis-
charged alive from the ICU and if they were more than
17 years old. Discharged criteria were clinical improve-
ment without need of further organ support and/or
intensive monitoring. Patients were followed until hospi-
tal death or hospital discharge. Only the first ICU
admission was included.
The clinical predictors analyzed included Acute Phy-
siology and Chronic Health Evaluation (APACHE) II
[10], Simplified Acute Physiology Score (SAPS) II [11],
Sequential Organ Failure Assessment scores (SOFA)
[12] and Therapeutic Intervention Scoring System-28
(TISS-28) [13].
C-reactive protein, body temperature and white cells
count (WCC) were measured at admission and then
daily until discharge.
Measurement of CRP was performed by an immuno-
turbidimetric method (Tina-quant CRP; Roche Diagnos-
tics, Mannheim, Germany).
We compared the clinical and laboratory data of
survivors and nonsurvivors after ICU discharge.
A subgroup analysis between infected and non-
infected patients was performed. Surgical and medical
patients were also analyzed. We considered that the
patient belong to the surgical group if the main reason
of ICU admission was surgical, obstetric or trauma.
Statistical Analyses
The outcome measure was post-ICU mortality. Continu-
ous variables are presented as mean +/- standard devia-
tion (SD), unless stated otherwise. Differences in
continuous variables were performed with the para-
metric unpaired Student’s t test and one-way ANOVA
or with the nonparametric Mann-Whitney U-test or
Kruskal-Wallis H-test according to data distribution.
The Chi-square test was used to carry out comparisons
between categorical variables.
C-reactive protein levels were categorized in three
groups (CRP <5, 5-10, >10 mg/dL) and compared with
mortality rate. Linear regression analysis was used to
compare SOFA with CRP levels. Discrimination of
APACHE II, SAPS II, SOFA, TISS-28, CRP, body tem-
perature and WCC was tested to produce receiver-oper-
ating characteristic (ROC) curves. Areas under curves
(AUC), with 95% confidence intervals (CI) were calcu-
lated in prediction of ICU mortality. A p value below
0.05 was considered statistically significant. Statistical
analyses were performed using SPSS 16.0 software.
Results
During a 14-month period a total of 262 patients were
admitted in the ICU. The overall ICU mortality was
40%.
One hundred and fifty six patients were discharged
alive from ICU to ward with a mean age of 55 ± 18 and
93 (60%) were males (Table 1).
A total of 29 patients (18.6%) died in hospital after
ICU discharge. Clinical and demographic characteristics
of post-ICU survivors and nonsurvivors are presented in
table 1. The mean duration of follow-up post-ICU dis-
charge was 34.8 days, with no difference between survi-
vors and nonsurvivors (34.3 ± 26.8 versus 37.6 ± 24.9
days; p = NS). Nonsurvivors were sicker with higher
levels of APACHE II, SAPS II, SOFA and TISS-28.
(Table 1).
C-reactive protein was determined in all patients at
ICU discharge. C-reactive protein values varied from
0.15 to 43.5 mg/dL.
Although 25% higher in nonsurvivors, CRP levels at ICU
discharge was not significantly difference in relation to
survivors (survivors - 8.1 ± 8.0 vs. nonsurvivors - 10.2 ±
12.0 mg/dL; p = NS). In addition, no correlation could be
found between higher CRP levels and mortality. Post-ICU
mortality rate of the patients with CRP <5, between 5-10,
>10 mg/dL was 15.1% (N = 9), 16.1% (N = 9) and 33.3%
(n = 11) respectively (p = NS).
The area under the ROC curves of APACHE II, SAPS
I I ,T I S S - 2 8 ,S O F A ,C R P ,W C Ca n db o d yt e m p e r a t u r e
and at ICU discharge as prognostic markers of post-ICU
death were 0.76 (95% CI 0.67-0.86), 0.75 (95% CI 0.67-
0.86), 0.72 (95% CI 0.62-0.83), 0.64 (95% CI 0.52-0.77),
0.55 (95% CI 0.43-0.68), 0.56 (95% CI 0.44-0.67) and
0.54 (95% CI 0.44-0.67) respectively (Figure 1).
CRP as a prognostic marker in patients with previous
documented infection
One hundred and thirty six out of 262 of the patients
discharged from ICU presented at least one documented
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Page 2 of 6Table 1 Baseline characteristics of the patients discharged from the Intensive care Unit
All (n = 156) Survivors (n = 127) Nonsurvivors (n = 29) p values
Age, yrs 55 ± 18 53 ± 19 62 ± 12 NS
Sex (M/F) 93/63 79/48 14/15 NS
APACHE II 14.6 ± 6.2 13.4 ± 5.3 20.0 ± 7.1 <0.001
SAPS II 28.6 ± 12.7 25.9 ± 9.6 40.5 ± 17.5 <0.001
TISS-28 25.1 ± 5.3 24.2 ± 4.3 28.8 ± 7.1 <0.001
SOFA 3.5 ± 2.7 3.0 ± 1.8 5.6 ± 4.7 <0.001
CRP (mg/dL) 8.5 ± 8.3 8.1 ± 8.0 10.1 ± 9.5 NS
Temperature (ºC) 36.9 ± 2.7 36.8 ± 3.0 37.2 ± 0.8 NS
WCC (x1000)/mL 11.3 ± 7.4 10.6 ± 6.0 14.4 ± 11.4 NS
Admission diagnosis (N)
Respiratory 47 35 12
Trauma 24 21 3
Surgical 21 17 4
Cardiovascular 21 17 4
Neurological 14 13 1
Obstetrics 6 6 0
Gastroenterological 6 5 1
Others 17 13 4
Values expressed as mean ± standard deviation
Figure 1 Receiver operating characteristics (ROC) curves of Simplified Acute Physiology Score (SAPS) II, Acute Physiology and Chronic
Health Evaluation (APACHE) II, Therapeutic Intervention Scoring System-28 (TISS-28), Sequential Organ Failure Assessment (SOFA)
scores, serum C- reactive protein (CRP), body temperature and white cell count (WCC).
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17 years and 83 (61%) were males.
The primary reason for ICU admission was respiratory
failure due to pneumonia. The in-hospital mortality rate
from the patients with documented infection was 21%.
At ICU discharge, CRP values varied from 0.15 to 43.5
mg/dL (median 5.7 mg/dL). No differences in CRP
levels were observed between survivors and nonsurvi-
vors (8.4 ± 8.2 vs. 10.3 ± 9.6 mg/dL, p = NS, respec-
tively) after discharge. However, the SAPS II, APACHE
II, TISS-28 and SOFA score were significantly higher in
nonsurvivors (Table 2).
The AUC showed a good discriminative power of
post-ICU mortality for TISS-28 (AUC 0.75; 95% CI
0.665-0.86), SAPS II (AUC 0. 77; 95% CI 0.68-0.87) and
APACHE II score (AUC 0.78; 95% CI 0.68-0.87). For
CRP levels the AUC did not demonstrate a good discri-
minative power of post-ICU mortality (AUC 0.55; 95%
CI 0.42-0.67).
CRP as a prognostic marker in surgical and medical
patients
In 51 patients the main admission diagnosis was surgical.
The mean age was 49 ± 19 years and 33 (65%) were male.
The post-ICU mortality rate was 14% and no differences
were observed between surgical and medical patients.
C-reactive protein levels at ICU discharge were signifi-
cantly higher than in medical patients (6.5 ± 7.0 vs. 12.5
± 9.2; p < 0.001). However no differences in CRP levels
at ICU discharge could be found between survivors and
nonsurvivors in both surgical and medical patients (5.9
± 6.7 mg/dL vs. 8.7 ± 8.9 mg/dL; p = NS and 12.2 ± 8.6
mg/dL vs. 14.6 ± 13.0; p = NS, respectively).
CRP also did not demonstrate a good discriminative
power of post-ICU mortality (Medical Group: AUC 0.
51; 95% CI 0.19-0.82 and Surgical Group: AUC 0.38;
95% CI 0.24-0.52).
Discussion
In this prospective observational study with 156 patients
discharged alive from ICU, we evaluated the relation
between CRP levels at ICU discharge and post-ICU
mortality. Our data demonstrate that CRP at ICU dis-
charge was not correlated with in-hospital mortality.
Even in patients with higher levels of CRP (>10 mg/dL)
there was no significant increase in post-ICU mortality.
In the subgroup analysis these data were similar and no
association could be found between CRP levels and
post-ICU mortality in patients with previous documen-
ted infection and in medical and surgical patients.
In a heterogeneous ICU patient population, Lobo et al.
showed that admission CRP levels correlated with an
increased risk of organ failure and death [14]. In addition,
our group showed that persistently elevated CRP concen-
trations in infected critically ill patients were associated
with poor outcome [15,16]. Recently, it has been
described that in survivors of an acute infection could
present a state of persistent inflammation that may lead
to deterioration of other diseases, such as cardiovascular
disease, and an increased long-term mortality [7].
Long-term mortality has been assessed in a recent mul-
ticenter study conducted by Yende et al. [8]. Authors
included 1799 patients discharged from emergency
department with a primary diagnosis of community
pneumonia. Interleukin-6 (IL-6) concentrations at hospi-
tal discharge were higher among subjects who did not
survive at 100 days compared with those who survived
(12.9 vs. 6.6 pg/mL, p < 0.001). This difference was not
obtained among those who did and did not survive
between 101 days and 1 year (7.7 vs. 6.5 pg/mL, p = NS).
However, nonsurvivors compared with survivors at 1
year, nonsurvivors were older, had more co-morbid con-
ditions, as evidenced by higher Charlson scores, and had
more severe CAP on presentation, as evidenced by higher
Pneumonia Severity Index and APACHE III scores.
In a recently published study by Ho et al. [6], that
analyzed short-term mortality among ICU patients, a
significant association between CRP concentrations at
ICU discharge and subsequent in-hospital mortality was
identified. In this prospective cohort study of 603 conse-
cutive patients who survived their first ICU admission,
CRP concentrations at ICU discharge were associated
with subsequent in-hospital mortality in the univariate
analysis (non-survivors -17.4 vs. survivors - 8.56 mg/l, p
= 0.001).
In our study we were unable to reproduce these find-
ings, since CRP was a poor prognostic marker of post-
ICU mortality (AUC 0.55; 95% CI 0.42-0.67). However,
in Ho et al. study [6], CRP concentrations were available
only in 73% of the nonsurvivors and the number of
unexpected post-ICU deaths was small (4.3%). Hence
the results could be imprecise and may not be extrapo-
lated to ICUs with higher post-ICU mortality rates.
In opposition, our data does not support the use of
CRP in outcome prediction in critically ill patients,
Table 2 Baseline characteristics of the patients with
documented infection
Survivors (n = 127) Nonsurvivors (n = 29) p values
Age, yrs 54 ± 18 62 ± 12 p =N S
Sex (M/F) 69/39 14/14 p =N S
APACHE II 13.7 ± 4.9 20.3 ± 10.0 p < 0.001
SAPS II 26.2 ± 8.8 41.3 ± 17.2 p < 0.001
TISS-28 24.1 ± 3.6 29.1 ± 7.1 p < 0.001
SOFA 3.0 ± 1.7 5.7 ± 4.7 p < 0.001
CRP (mg/dL) 8.4 ± 8.2 10.3 ± 9.6 p =N S
Values expressed as mean ± standard deviation
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tion had higher APACHE II, SOFA scores and TISS-28
as well as a larger subgroup of patients with documen-
ted infection.
In a recently published study, we also could not found
a relation between CRP levels of the day of sepsis diag-
nosis and ICU survival [17]. Both these results demon-
strate that, despite CRP has been repeatedly shown to
be a sensitive marker of infection; it predicts poorly the
patient outcome.
Our study has some limitations. First, this was a
cohort single centre study with only 8 beds of intensive
care. Second a mixed group of medical and surgical
patients were included; whether CRP will have a better
performance in a particular subgroup of patients, for
example in patients with lower respiratory tract infec-
tion remains uncertain, but deserves further investiga-
tion. Finally severity scores were used at ICU discharge,
however these scores were only developed and validated
to be used in the first 24 hours after ICU admission.
Our study design had some distinctions: we analyzed
separately the patients with previous documented infec-
tion as well as medical and surgical patient, and patients
with end-life limitations were not excluded.
Conclusions
Some studies suggest that persistent inflammation may
precipitate deterioration in other diseases, such as cardi-
ovascular disease, and increase long-term mortality [7].
In our data no correlation between CRP concentrations
at ICU discharge and post-ICU hospital mortality could
be found, with post-ICU survival appearing to be unre-
lated to higher levels of inflammatory biomarkers. Rea-
sons for increased long and short - term mortality
among ICU survivors are not fully understood. As a
result, future studies are needed to explore the relation-
ship between biomarkers on subsequent health-related
outcomes.
Key messages
￿ I nt h ep r e s e n ts t u d yC - r e a c t i v ep r o t e i nc o n c e n t r a -
tions at ICU discharge were not related to post-ICU
hospital outcome. C-reactive protein despite being a
sensitive marker of infection, it predicts poorly the
patient outcome.
￿ Similar results were observed in the subgroup of
ICU survivors with documented infection.
￿ C-reactive protein also did not demonstrate a good
discriminative power of post-ICU mortality between
medical and surgical patients.
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